IRAK1 promotes cell proliferation and protects against apoptosis in HCC, and can be a novel target for HCC treatment.
No takes yet. Share an insight, caveat, or question.
Li et al. (2016) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: